Twelve Months with COVID-19: What Gastroenterologists Need to Know
- PMID: 34333726
- PMCID: PMC8325547
- DOI: 10.1007/s10620-021-07158-0
Twelve Months with COVID-19: What Gastroenterologists Need to Know
Abstract
Corona virus disease-19 (COVID-19) is the latest global pandemic. COVID-19 is mainly transmitted through respiratory droplets and, apart from respiratory symptoms, patients often present with gastrointestinal symptoms and liver involvement. Given the high percentage of COVID-19 patients that present with gastrointestinal symptoms (GIS), in this review, we report a practical up-to-date reference for the physician in their clinical practice with patients affected by chronic gastrointestinal (GI) diseases (inflammatory bowel disease, coeliac disease, chronic liver disease) at the time of COVID-19. First, we summarised data on the origin and pathogenetic mechanism of SARS-CoV-2. Then, we performed a literature search up to December 2020 examining clinical manifestations of GI involvement. Next, we illustrated and summarised the most recent guidelines on how to adhere to GI procedures (endoscopy, liver biopsy, faecal transplantation), maintaining social distance and how to deal with immunosuppressive treatment. Finally, we focussed on some special conditions such as faecal-oral transmission and gut microbiota. The rapid accumulation of information relating to this condition makes it particularly essential to revise the literature to take account of the most recent publications for medical consultation and patient care.
Keywords: COVID-19; Coeliac disease; Gastrointestinal symptoms; Inflammatory bowel disease; Liver diseases; SARS-CoV-2.
© 2021. The Author(s).
Conflict of interest statement
The authors have no conflicts of interest relevant to this article to disclose.
Similar articles
-
What GI Physicians Need to Know During COVID-19 Pandemic.Dig Dis Sci. 2021 Sep;66(9):2865-2875. doi: 10.1007/s10620-020-06625-4. Epub 2020 Oct 5. Dig Dis Sci. 2021. PMID: 33015748 Free PMC article. Review.
-
COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.World J Gastroenterol. 2020 Aug 21;26(31):4579-4588. doi: 10.3748/wjg.v26.i31.4579. World J Gastroenterol. 2020. PMID: 32884218 Free PMC article. Review.
-
COVID-19 - more than respiratory disease: a gastroenterologist's perspective.J Physiol Pharmacol. 2020 Apr;71(2). doi: 10.26402/jpp.2020.2.02. Epub 2020 Jul 2. J Physiol Pharmacol. 2020. PMID: 32633236 Review.
-
COVID-19 induces gastrointestinal symptoms and affects patients' prognosis.J Int Med Res. 2022 Oct;50(10):3000605221129543. doi: 10.1177/03000605221129543. J Int Med Res. 2022. PMID: 36238995 Free PMC article. Review.
-
Implications of SARS-COV-2 infection in the diagnosis and management of the pediatric gastrointestinal disease.Ital J Pediatr. 2021 Mar 24;47(1):71. doi: 10.1186/s13052-021-01020-9. Ital J Pediatr. 2021. PMID: 33761992 Free PMC article. Review.
Cited by
-
Limited Additive Diagnostic Impact of Isolated Gastrointestinal Involvement for the Triage of Children with Suspected COVID-19.Children (Basel). 2022 Jan 2;9(1):41. doi: 10.3390/children9010041. Children (Basel). 2022. PMID: 35053666 Free PMC article.
-
Celiac Disease and Targeting the Molecular Mechanisms of Autoimmunity in COVID Pandemic.Int J Mol Sci. 2022 Jul 13;23(14):7719. doi: 10.3390/ijms23147719. Int J Mol Sci. 2022. PMID: 35887067 Free PMC article. Review.
-
Associations Between Gastrointestinal Symptoms and COVID-19 Severity Outcomes Based on a Propensity Score-Weighted Analysis of a Nationwide Cohort.Gastro Hep Adv. 2022;1(6):977-984. doi: 10.1016/j.gastha.2022.06.015. Epub 2022 Aug 7. Gastro Hep Adv. 2022. PMID: 35966642 Free PMC article.
References
-
- World Health Organization. Covid-19 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/2.... Accessed 03.06.20.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous